Your browser doesn't support javascript.
loading
Severe Congenital Neutropenia Type 4: A Rare Disease Harboring a G6pc3 Gene Pathogenic Variant Particular to the Mexican Population
López-Rodríguez, Larissa; Svyryd, Yevgeniya; Benítez-Alonso, Edmar O.; Rivero-García, Pamela; Luna-Muñoz, Leonora; Mutchinick, Osvaldo M..
  • López-Rodríguez, Larissa; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
  • Svyryd, Yevgeniya; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
  • Benítez-Alonso, Edmar O.; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
  • Rivero-García, Pamela; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
  • Luna-Muñoz, Leonora; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
  • Mutchinick, Osvaldo M.; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Department of Genetics. Mexico City. MX
Rev. invest. clín ; 74(6): 328-339, Nov.-Dec. 2022. tab, graf
Article Dans Anglais | LILACS-Express | LILACS | ID: biblio-1431821
ABSTRACT
ABSTRACT

Background:

Severe congenital neutropenia type 4 (SCN4) is a rare autosomal recessive granulopoiesis disorder caused by G6PC3 gene pathogenic variants. The estimated prevalence is 1/10,000,000 people. Over 90% of patients present a syndromic form with variable multisystemic involvement, including congenital heart defects, increased visibility of superficial veins (IVSV), inflammatory bowel disease, and congenital urogenital defects as prominent symptoms.

Objectives:

The objective of the study was to study non-hematological phenotypic findings that suggest a clinical diagnosis of SCN4.

Methods:

We examined medical records of patients diagnosed with neutropenia from January 2000 to December 2020, selecting cases with non-hematologic manifestations for phenotypic description and G6PC3 gene sequencing.

Results:

We found 11 cases with non-hematologic features congenital heart defects in 8, IVSV in 6, inflammatory bowel disease in 4, urogenital defects in 4, and similar facial appearance. In addition, Sanger sequencing confirmed 3 homozygous cases for the c.210delC variant, a compound heterozygous harboring this variant, and a c.199_218+1 deletion.

Conclusions:

Our findings of the c.210delC variant in very close geographical settings, to date, have only been reported among Mexicans, and a mutual uncommon surname in two families strongly supports a founder effect for the variant in the studied population. Furthermore, the described non-hematologic symptoms in patients with severe primary neutropenia should be explored, confirming SCN4 by investigating G6PC3 gene mutations.


Texte intégral: Disponible Indice: LILAS (Amériques) Type d'étude: Facteurs de risque Pays comme sujet: Mexico langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2022 Type: Article Pays d'affiliation: Mexique Institution/Pays d'affiliation: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán/MX

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Type d'étude: Facteurs de risque Pays comme sujet: Mexico langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2022 Type: Article Pays d'affiliation: Mexique Institution/Pays d'affiliation: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán/MX